VIR
Vir Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.21
+2.51%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 27.40x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.76x
- Price / sales
- 5.70x
- Price / cash flow
- -8.53x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 4.26x
- EV / EBITDA
- -4.82x
- EV / EBIT
- -4.62x
- Market cap
- $1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026